ABVC BioPharma, Inc. (ABVC) vs 4D pharma PLC Sponsored ADR (LBPS)

ABVC BioPharma, Inc. and 4D pharma PLC Sponsored ADR are both Biotechnology companies. ABVC BioPharma, Inc. and 4D pharma PLC Sponsored ADR are of similar size ($37.2M and $34.0M). ABVC BioPharma, Inc. has the higher net margin (0.00% vs −9,577.1%) and the lower return on invested capital (−33.5% vs 0.00%). Across the 16 metrics below, ABVC BioPharma, Inc. leads on 12 and 4D pharma PLC Sponsored ADR on 4.

Valuation

Metric ABVC LBPS Biotechnology median
P/E n/m n/m 7.88
P/S 22.77 211.23 11.47
P/B 2.42 9.49 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 24.03 205.89 10.73
Earnings yield (29.79%) (40.76%) (28.84%)
Free cash flow yield (9.14%) (30.32%) (23.03%)

Profitability

Metric ABVC LBPS Biotechnology median
Gross margin 99.97% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (9,577.06%) 0.00%
Free cash flow margin 0.00% (6,318.73%) 0.00%
Return on equity (65.32%) (742.15%) (57.72%)
Return on assets (39.88%) (371.23%) (49.22%)
Return on invested capital (33.45%) 0.00% 0.00%

Growth

Metric ABVC LBPS Biotechnology median
Revenue growth (TTM) 5,035.43% — 5.64%
EPS growth (last fiscal year) 7.14% 35.04% —
Revenue growth, 5-year CAGR (6.20%) 21.70% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABVC LBPS Biotechnology median
Debt to equity 0.00 0.43 0.00
Current ratio 0.07 5.21 4.73
Net debt to EBITDA 0.21 0.23 0.96

Dividend

Metric ABVC LBPS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ABVC LBPS Biotechnology median
Market cap 33.96m 37.19m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack